BRILINTA
- Product NDC
- 71610-815
- 11-digit product format
- 716100815
- Labeler code
- 71610
- Product ID
- 71610-815_159d6ad1-edcf-d4da-e063-6294a90a6adb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ticagrelor
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA022433
- Marketing category
- NDA
- Marketing start
- 2011-08-05
- Substance
- TICAGRELOR
- Active strength
- 90 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BRILINTA
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TICAGRELOR | 90 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GLH0314RVC |
| Rxcui | 1116635, 1116639 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-815-41 | BRILINTA | 5400 in 1 BOTTLE | TABLET | 5400 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-815 | BRILINTA (TICAGRELOR) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC ] | 2 | Current NDC, 1 package rows | 20240410_1547e2b6-8858-178e-e063-6394a90abb23.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-815-41 | 71610081541 | 5400 TABLET in 1 BOTTLE (71610-815-41) | 5400 tablet | 2024-04-03 | No | No | Historical |